global nano medicine market
Brochure
More information from http://www.researchandmarkets.com/reports/2617729/
Global Nanomedicine Market 2012-2016
Description:
The analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period
2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The
Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market.
The report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and
APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb
Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc.
The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead
Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante
Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences
Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc., Nanobiotix
S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc., Nanotherapeutics
Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding AG, Skyepharma PLC,
Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and Tecan Group Ltd.
Key questions answered in this report:
- What will the market size be in 2016 and what will be the growth rate?
- What are key market trends?
- What is driving this
More information from http://www.researchandmarkets.com/reports/2617729/
Global Nanomedicine Market 2012-2016
Description:
The analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period
2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The
Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market.
The report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and
APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb
Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc.
The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead
Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante
Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences
Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc., Nanobiotix
S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc., Nanotherapeutics
Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding AG, Skyepharma PLC,
Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and Tecan Group Ltd.
Key questions answered in this report:
- What will the market size be in 2016 and what will be the growth rate?
- What are key market trends?
- What is driving this